Showing results (431-440 of 1,350) with videos related to

Sort By:
Pageof 135
Clinical Pharmacology in Drug Development|June 9, 2025
Comparative Pharmacokinetics and Bioequivalence of Two Sodium Valproate Tablets in Healthy Chinese Subjects Under Fasting and Fed ConditionsYuan Liu, Xueqiong Peng, Mengfei Zhao, et al.
Clinical Pharmacology in Drug Development|May 27, 2025
Combined Immediate-Release and Extended-Release Formulation of Sodium Valproate Provides Stable Plasma Levels for Inhibition of Histone DeacetylationNikhil Ahuja, Susanna Kääriäinen, Zsófia Lovró, et al.
Clinical Pharmacology in Drug Development|September 29, 2025
Pharmacokinetics, Bioequivalence, and Safety of Bromocriptine Mesylate Tablets in HealthyChinese SubjectsHuan Song, Yujun Chen, Lianlian Chen, et al.
Clinical Pharmacology in Drug Development|July 3, 2025
A Double-Blind, Placebo-Controlled, Single-Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HT-101, an RNAi Therapeutic Targeting HBV InfectionJianxiong Zhang, Jiangshuo Li, Le Wu, et al.
Clinical Pharmacology in Drug Development|January 16, 2026
Impact of Sampling Window Variability on Pharmacokinetic Parameters Estimated by Non-Compartmental Analysis: Case Studies of Various Types of DrugsKyosuke Takahashi, Kazuhiko Asari, Kazuhiko Hanada
Clinical Pharmacology in Drug Development|April 17, 2025
A Phase 1 Study to Evaluate the Absorption, Metabolism, and Disposition of Dordaviprone in Healthy Adult ParticipantsYohannes Teffera, Tim Tippin, Angela Bartkus, et al.
Clinical Pharmacology in Drug Development|May 14, 2025
Effect of Mild to Moderate Hepatic Impairment on Valemetostat Pharmacokinetics: An Open-Label, Phase I StudyMasaya Tachibana, Thuy Vu Craveiro, Thomas C Marbury, et al.
Clinical Pharmacology in Drug Development|May 16, 2025
Safety, Tolerability, and Pharmacokinetics of Donanemab in Healthy Chinese Participants: A Phase 1, Randomized, Double-Blind, Placebo-Controlled StudyJunyu Xu, Nan Zhao, Yihui Wang, et al.
Clinical Pharmacology in Drug Development|May 22, 2025
Pharmacokinetics, Safety, and Tolerability of Single-Dose Dazukibart in Healthy Adults in China and Japan: Results From 2 Randomized, Double-Blind, Phase 1 StudiesNaihan Chen, Yamato Sano, Xiaohong Wang, et al.
Clinical Pharmacology in Drug Development|April 21, 2025
A Phase 1 Study to Evaluate the Pharmacokinetics and Safety of TPN171 (a PDE5 Inhibitor) in Adults with Renal ImpairmentPing Fu, Yi Song, Chao Hu, et al.
Pageof 135